Peer Schatz

Former CEO of QIAGEN

Appears in 1 story

Born: August 3, 1965, New York City

Education: Booth School of Business, University of Chicago, University of St. Gallen

Last updated Nov 2, 2026

Stories

EQT agrees to take QIAGEN private in all-cash takeover offer

Money Moves

Departed October 2019; his exit made QIAGEN a takeover target

Swedish buyout firm EQT Private Equity agreed to buy Dutch molecular testing company QIAGEN for €46.50 a share in cash, valuing it at about $12.1 billion including roughly $1.1 billion of net debt. The price is 40.3% above QIAGEN's €33.15 close on July 8, the last trading day before reports of private equity interest surfaced.

Updated Oct 23